Results 151 to 160 of about 15,076,620 (365)
TRANSACTIONS OF THE NEW YORK SURGICAL SOCIETY Stated meeting, held at the New York Academy of Medicine, March 11, 1914 The President, DR. FREDERIC KAMMERER, in the Chair [PDF]
, 1914 NULL AUTHOR_ID
openalex +1 more source
PARTICULARITIES OF THE LOGISTIC OPERATIONS IN THE PHARMACEUTICAL DOMAIN [PDF]
The management of logistic operations has a very important role in the case of pharmaceutical products. The purpose of this article is to analyze the particularity of the logistic operations management in the pharmaceutical domain.
BUTNARU, Ana, ŞERBULESCU, Luminiţa
core
Molecular Oncology, EarlyView.This study identifies nuclear YB‐1 S102 phosphorylation as a marker associated with KRAS and FBXW7 mutations in colorectal cancer. Mutated KRAS correlates specifically with nuclear, not cytoplasmic, S102 YB‐1. These findings provide the first ex vivo evidence of this link in CRC and suggest future studies should assess the prognostic and therapeutic ...
Konstanze Lettau +9 more
wiley +1 more source
A nucleotide‐independent, pan‐RAS‐targeted DARPin elicits anti‐tumor activity in a multimodal manner
Molecular Oncology, EarlyView.We report a Designed Ankyrin Repeat Protein that binds and inhibits RAS proteins, which serve as central cell signaling hubs and are essential for the progression of many cancers. Its unique feature is that it does not discriminate between different RAS isoforms or mutations and is capable of binding to RAS in both its active (GTP‐bound) and inactive ...
Jonas N. Kapp +13 more
wiley +1 more source
The state of emergency medicine in Greece: at critical momentum
International Journal of Emergency MedicineGreece is a parliamentary republic in southeastern Europe populated by over 10 million permanent residents: 9 million reside on the mainland, with almost 4 million in the greater Athens area.
Dimitrios Tsiftsis +4 more
doaj +1 more source
Molecular Oncology, EarlyView.C–C chemokine receptor type 9 (CCR9) is an immune checkpoint in pancreatic ductal adenocarcinoma (PDAC). Novel anti‐CCR9 antibody SRB2 was evaluated in combination with cytotoxic chemotherapy in PDAC cells, patient‐derived organoids, patient‐derived xenografts, and humanized mouse models.
Hannah G. McDonald +18 more
wiley +1 more source
Preventive medicine for prevention measurement for COVID-19, State quarantine
International Journal of Preventive Medicine, 2021 Viroj Wiwanitkit
doaj +1 more source
Unraveling LINE‐1 retrotransposition in head and neck squamous cell carcinoma
Molecular Oncology, EarlyView.The novel RetroTest method allows the detection of L1 activation in clinical samples with low DNA input, providing global L1 activity and the identification of the L1 source element. We applied RetroTest to a real‐world cohort of HNSCC patients where we reported an early L1 activation, with more than 60% of T1 patients showing L1 activity.
Jenifer Brea‐Iglesias +12 more
wiley +1 more source